Researchers and physicians can now quantify:
- Capillary density
- Capillary blood volume
- Blood flow and red cell velocity
- Endothelial glycocalyx function
GlycoCheck measures and analyzes microvascular health, and objectively reports a MicroVascular Health Score (MVHS). Lower scores are linked to:
- Heart Disease
- Kidney Disease
- Septic Shock
- Inflammatory Disorders
- Compromised Immunity
- Cancer Metastasis
The endothelial glycocalyx is a vast protective micro-thin gel lining of all capillaries that touch each of the trillions of cells. The capillaries represent 99% of the circulatory system.
Endothelial glycocalyx research is taking place in universities and hospitals around the world. It’s a unique asset in research departments for automated video analysis of the microvascular system.
GlycoCheck is a non-invasive test. A video microscope camera is placed under the tongue showing live movement of red blood cells as they travel through microvessels.
GlycoCheck is the only system that allows researchers to unravel the mysteries of microcirculation and how its breakdown contributes to the development of various diseases.
The integrity of the glycocalyx structure and function is important because the continuous delivery of nutrients and hormones, and the elimination of waste, flows through the capillaries.
Many clinical research studies are underway and peer-reviewed papers continue to be published worldwide that links endothelial glycocalyx health to conditions and diseases.
There are 3,000 vascular segments per test. These segments process 3,000,000 capillary markers tracking the movement of the red blood cells and how they interact with the endothelial glycocalyx.
GlycoCheck System Information
- November 10, 2020
- June 14, 2021
- December 31, 2020
- October 28, 2020
- July 14, 2020